Trials / Withdrawn
WithdrawnNCT01984814
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on the Survival Duration in Amyotrophic Lateral Sclerosis - A Retrospective Control Study
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 26 Years – 76 Years
- Healthy volunteers
- Not accepted
Summary
The effect of autologous bone marrow mononuclear cells on duration of survival in Amyotrophic Lateral Sclerosis patients.
Detailed description
Survival duration in Amyotrophic Lateral Sclerosis patients who received cellular transplantation was compared to patients who did not receive cellular transplantation. Kaplan-Meier survival analysis was used for this comparison.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stem cell | Autologous bone marrow derived mononuclear cells were administered via intrathecal and intramuscular routes. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-11-15
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01984814. Inclusion in this directory is not an endorsement.